Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas originate from B-cell compartments with two different antigen-exposure histories.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 18305562)

Published in Leukemia on February 28, 2008

Authors

M Parrens, N Gachard, B Petit, A Marfak, E Troadec, K Bouabdhalla, N Milpied, J P Merlio, A de Mascarel, C Laurent, I Soubeyran, V Coste, F Labrousse, M Cogné, J Feuillard

Articles by these authors

Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer (1984) 3.94

Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg (1998) 3.45

Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut (2001) 2.62

Viridans streptococcal bacteraemia in patients with neutropenia. Lancet (1995) 2.46

Low prevalence of monoclonal B cells in Helicobacter pylori gastritis patients with duodenal ulcer. Hum Pathol (1998) 2.11

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood (1992) 2.11

Gastric large cell lymphoma expressing cytokeratin but no leukocyte common antigen. A diagnostic dilemma. Am J Clin Pathol (1989) 2.11

Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia (2003) 1.96

Localization of the 3' IgH locus elements that effect long-distance regulation of class switch recombination. Immunity (2001) 1.95

Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients. J Antimicrob Chemother (1992) 1.92

[Staining of human chromosomes with acridine orange after treatment with 5 bromodeoxyuridine]. C R Acad Sci Hebd Seances Acad Sci D (1973) 1.89

NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development (1996) 1.89

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer. Ann Oncol (2004) 1.85

Intersphincteric resection with excision of internal anal sphincter for conservative treatment of very low rectal cancer. Dis Colon Rectum (1999) 1.83

Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia (2001) 1.82

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol (2000) 1.73

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood (2001) 1.71

Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet (2000) 1.68

Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut (1999) 1.66

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood (2001) 1.63

A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein. Protein Eng (2001) 1.59

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia (2012) 1.57

Cutaneous localization of chronic lymphocytic leukemia at the site of chickenpox. J Am Acad Dermatol (1997) 1.54

Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood (2001) 1.51

[Acupuncture worth trying in severe tinnitus]. Lakartidningen (1998) 1.50

Thymoma-associated pancytopenia: effectiveness of cyclosporine A. Ann Hematol (1998) 1.47

Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol (2001) 1.47

Interleukin-2 treatment in lymphoma: a phase II multicenter study. Blood (1994) 1.46

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation (1997) 1.46

Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 1.46

Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients. Bone Marrow Transplant (1995) 1.45

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44

Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol (1999) 1.42

Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Leukemia (1997) 1.41

CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases. Am J Clin Pathol (1996) 1.41

[Pericentric inversion, inv(10), in a mother and aneusomy by recombination, inv(10), rec(10), in her son (author's transl)]. Cytogenet Cell Genet (1973) 1.40

[Necrotizing amebic colitis]. Gastroenterol Clin Biol (1994) 1.40

Diffuse small intestinal lymphoid infiltration in nonimmunodeficient adults from Western Europe. Gastroenterology (1988) 1.40

Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. J Clin Oncol (2000) 1.39

[Children arthropod bites protective measures: insecticides and repellents]. Arch Pediatr (2007) 1.39

Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int (1994) 1.38

Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). Br J Haematol (1997) 1.33

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial. J Clin Oncol (1998) 1.31

Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) Blood (1990) 1.30

Loop ileostomy versus loop colostomy for defunctioning low anastomoses during rectal cancer surgery. World J Surg (2001) 1.30

Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein. Protein Expr Purif (2001) 1.29

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet (1994) 1.29

Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. Br J Pharmacol (2006) 1.29

Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut (2003) 1.29

The 3' IgH regulatory region: a complex structure in a search for a function. Adv Immunol (2000) 1.28

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood (2000) 1.27

In-vitro activity of erythromycin, roxithromycin and CP 62993 against common paediatric pathogens. J Antimicrob Chemother (1987) 1.26

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM). Blood (1997) 1.26

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT. Leukemia (2012) 1.26

Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer (2005) 1.24

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle. Blood (1996) 1.23

Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Leukemia (2012) 1.23

Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia (2007) 1.22

Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. Differentiation (1988) 1.22

Liver resection of colorectal metastases in elderly patients. Br J Surg (2010) 1.21

Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol (2002) 1.21

Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood (2001) 1.20

Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin Chem (1999) 1.20

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire. Leukemia (2010) 1.20

The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma. Surg Endosc (2005) 1.17

Second-generation three-dimensional reconstruction for rotational three-dimensional angiography. Acad Radiol (1998) 1.17

[Four new cases of X-autosome translocation in man (author's transl)]. Humangenetik (1975) 1.17

Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol (1998) 1.16

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT. Bone Marrow Transplant (2013) 1.14

A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma. Ann Oncol (2007) 1.14

Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci (1992) 1.14

Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin. J Pathol (1988) 1.13

L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol (2008) 1.13

Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias. Leukemia (2009) 1.13

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM). Br J Haematol (2000) 1.13

Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature. Mod Pathol (1997) 1.13

Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. Cell Death Differ (2007) 1.13

Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis (2001) 1.12

Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol (1998) 1.12

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients. Ann Oncol (2012) 1.12

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia (2012) 1.11

Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine. Br J Dermatol (2001) 1.11

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers. Eur J Cancer (1998) 1.09

Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study. Bone Marrow Transplant (2002) 1.08

Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry (2012) 1.08